Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03714425 · ClinicalTrials.gov registry record · NA
Efficacy of the Quell Wearable Device for Fibromyalgia
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT03714425 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 119 participants.
The verdict
NCT03714425, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
This study is designed for patients with primary fibromyalgia (FM) pain. The overall aim of the study is to determine the effect of the high frequency Quell device to manage FM compared with a low frequency device. Investigators hypothesize that those assigned to using the high frequency Quell device will report reduced pain compared with those using the low frequency Quell device; with those using the high frequency device also showing more improvement in sleep, mood, and level of activity. Investigators also hypothesize that frequency of using the Quell (increased tolerability and adherence) will be correlated with greater reduction in pain.
Interventions
- DEVICE Quell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2020-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03714425
The ClinicalTrials.gov registry entry for NCT03714425 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quell is the first listed.
NCT03714425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03714425 about?
NCT03714425 is a clinical study titled "Efficacy of the Quell Wearable Device for Fibromyalgia". This study is designed for patients with primary fibromyalgia (FM) pain. The overall aim of the study is to determine the effect of the high frequency Quell device to manage FM compared with a low frequency device. Investigators hypothesize that those assigned to using the high frequency Quell devic...
What is the current status of trial NCT03714425?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2019-02-01. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT03714425?
The interventions under investigation include: Quell (DEVICE).
Who is sponsoring clinical trial NCT03714425?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.